Board-certified plastic surgeon and surgeon-scientist honored for clinical excellence, leadership, and commitment to patient ...

"Despite clear congressional mandates and FDA authorization, the Drug Enforcement Administration failed to act within the timelines required by law, resulting in years-long delay of medical cannabis ...

ASPS trend reporting highlights facelift combined with eyelid surgery as a leading 2025 combination; national procedure ...

SEATTLE, WA / ACCESS Newswire / December 26, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its ...

From combination surgeries to advanced skin therapies, The Naderi Center outlines how patients nationwide are prioritizing ...

The United States accounts for a significant share of the global remote patient monitoring (RPM) market. The U.S. RPM market ...

Expedited Development Enabled by RMAT and Breakthrough Therapy StatusClinical Trial Initiation in 2026, FDA Approval Target ...

Weekly Oral Helicase-Primase Inhibitor Programs' Early Data Potentially Supportive of First New Treatment for Recurrent ...

Ondine and Mid Yorkshire Teaching NHS Trust shortlisted for Excellence in Healthcare Partnership Award for Reducing Surgical Site Infections with Nasal Photodisinfection Second national award ...

Digital patient monitoring systems (DPMS) market refer to a broad spectrum of technologies designed to continuously monitor ...

This Christmas season, President Trump's executive action to advance rescheduling and medical research has finally exposed the truth: the DEA marijuana obstruction was never about public safety. It ...

Predicting how a person’s heart will respond to a new medicine remains one of the most persistent blind spots in drug ...